Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Proximal lower extremity DVT involving the femoral, common femoral, iliac veins, or inferior vena cava (IVC), alone or in combination.
* Willing and able to provide informed consent.
Exclusion Criteria:
* Prior venous stent in the target venous segment
* IVC aplasia/hypoplasia or other congenital anatomic anomalies of the IVC or iliac veins
* IVC filter in place at the time of the planned index procedure
* Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
* Life expectancy less than 1 year
* Chronic non-ambulatory status
* Known hypercoagulable states that, in the opinion of the Investigator, cannot be medically-managed throughout the study period
* Unavailability of a lower extremity venous access site
What they're measuring
1
Primary Safety Endpoint: Proportion Participants With Major Adverse Events